Serostim Study Group
This is where the potential benefits of peptides like BPC-157 come into focus
The Plot Twist: Unlike fad diets that fight against your biology, GLP-1 therapy works with your hunger signals, making sustainable weight management feel less like willpower and more like working smarter, not harder
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al
Working together to develop this novel obesity therapy represents an important addition to Lillys efforts to advance innovative treatment options for patients with metabolic disorders. Those efforts include Lillys own internally developed oral obesity candidate orforglipron, a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist